Septerna (SEPN) Share-based Compensation (2023 - 2026)

Septerna's (SEPN) quarterly Share-based Compensation came in at $6.0 million in Q1 2026, up 305.87% year-on-year from $1.5 million in Q1 2025, and up 203.35% quarter-over-quarter from -$5.8 million in Q4 2025.

Septerna (SEPN) Share-based Compensation (2023 - 2026) Analysis & Trends

Septerna's Share-based Compensation history runs 4 years deep, the most recent figure standing at $6.0 million for Q1 2026.

  • On a quarterly basis, Share-based Compensation rose 305.87% year-over-year to $6.0 million in Q1 2026; TTM through Mar 2026 was $3.5 million, a 14.15% decrease from a year earlier, with the FY2025 full-year figure at $24.5 million, up 63.33% from the prior year.
  • Share-based Compensation grew to $6.0 million in Q1 2026 per SEPN's latest filing, from -$5.8 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $25.1 million in Q3 2025 and bottomed at -$5.8 million in Q4 2025.
  • The 4-year median for Share-based Compensation is $1.3 million (2024), against an average of $4.0 million.
  • Biggest YoY gain for Share-based Compensation was 3574.96% in 2025; the steepest drop was 560.44% in 2025.
  • Year by year, Share-based Compensation stood at $11.5 million in 2023, then slumped by 89.04% to $1.3 million in 2024, then plunged by 560.44% to -$5.8 million in 2025, then jumped by 203.35% to $6.0 million in 2026.
  • Per Business Quant, the three latest SEPN Share-based Compensation figures stand at $6.0 million (Q1 2026), -$5.8 million (Q4 2025), and $25.1 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 6.39 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 9.26 Mn
4 NuCana 279.75 Bn 279.75 Bn - 1.18 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 166.40 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 257.40 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 87.30 Mn
10 Septerna 1.50 Bn 1.50 Bn - 6.02 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 6.02 Mn
Mar 31, 2026 6.02 Mn
Dec 31, 2025 -5.82 Mn
Dec 31, 2025 -5.82 Mn
Sep 30, 2025 25.10 Mn
Sep 30, 2025 25.10 Mn
Jun 30, 2025 1.81 Mn
Jun 30, 2025 1.81 Mn
Mar 31, 2025 1.48 Mn
Mar 31, 2025 1.48 Mn
Dec 31, 2024 1.26 Mn
Dec 31, 2024 1.26 Mn
Sep 30, 2024 683,000.00
Sep 30, 2024 683,000.00
Jun 30, 2024 628,000.00
Jun 30, 2024 628,000.00
Mar 31, 2024 577,000.00
Mar 31, 2024 577,000.00
Dec 31, 2023 11.53 Mn
Dec 31, 2023 11.53 Mn